Ovine IL-12 p70 quantitates ovine IL-12 p70 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant ovine IL-12 p70.
Ovine IL-12 p70 quantitates ovine IL-12 p70 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant ovine IL-12 p70.
Ovine IL-12 p70 quantitates ovine IL-12 p70 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant ovine IL-12 p70.
The interleukin-12 (IL-12) is a heterodimeric cytokine 70 kDa composed of two covalently bound glycosylated chains with molecular weights of 40 kD (p40) and 35 kD (p35). IL-12 is primarily produced by monocytes, macrophages, and dendritic cells in response to bacterial products such as lipopolysaccharides (LPS), intracellular pathogens, or interaction with activated T cells. Originally, IL-12 was discovered due to its ability to induce interferon-gamma (IFN-g) production, cell proliferation, and cytotoxicity mediated by natural killer cells and T cells. Studies have found that the IL-12 also plays a key role in the development of Th1 responses, leading to the production of l-IFN-g and l-IL-2. These cytokines can in turn promote T cell responses and macrophage activation. Recombinant mouse L-IL-12 p70 is produced in cells of insects infected with baculovirus as authentic heterodimer of subunits p35 and p40 precursors using a dual promoter expression system. IL-12 p70 is distinct from other available forms of protein in that it is expressed as a true heterodimer, as opposed to a single-chain pseudoheterodimer in which the subunits are joined by an artificial binder. The mediating of lymphocyte responses to this cytokine is ensured by STAT4 transcription protein activator. The 2A synthase of nitric oxide (NOS2A / NOS2) is necessary for the process of signalling this cytokine in innate immunity. The human and mouse L-IL-12 p40 shares about 70% of the amino acid sequence homology.